The company's low P/S ratio and declining revenue could worry investors. If top-line growth doesn't improve, the P/S could fall further. The company's declining revenue is a key factor in its low P/S ratio. If recent medium-term revenue trends continue, the share price may remain stagnant.
Emerson's acquisition of NI is expected to expand customer services, shareholder value, and endorse organic revenue growth towards 4-7%. With Ritu Favre as president, the Test & Measurement business remains in Austin, projecting continued growth.
奧斯汀科技集團股票討論區
$SeaStar Medical(ICU.US)$$Trxade Health(MEDS.US)$$尚高生命科學(SISI.US)$$奧斯汀科技集團(OST.US)$$微美全息(WIMI.US)$$Intuitive Machines(LUNR.US)$
📊⚡️📊
Careful here
暫無評論